Among different MAPK enzymes, ERK activation plays a central role in inhibiting ENaC function in inflammatory conditions such as ulcerative colitis, lymphocytic colitis and Crohn’s disease [18,19,20]. The gene discussed is MAPK1; the disease is lymphocytic colitis.